Unknown

Dataset Information

0

Mycoplasma suis Alpha-Enolase Subunit Vaccine Induces an Immune Response in Experimental Animals.


ABSTRACT: Recombinant protein technology has emerged as an excellent option for vaccine development. However, prior to our study, the immune induction ability of recombinant Mycoplasma suis alpha-enolase (rMseno) in animals remained unclear. The purpose of this study was to develop a rMseno protein subunit vaccine and to determine its ability to elicit an immunological response. To accomplish this, we cloned the gene into pET-15b, expressed it in BL21 cells, and purified it. Following the establishment of immunity, the immunogenicity and potential for protection of rMseno were evaluated in mice and piglets. The results demonstrate that anti-M. suis serum recognized the pure rMseno protein in both mice and piglets as evidenced by high levels of specific anti-rMseno antibodies, significantly increased levels of IFN-γ and IL-4 cytokines, and significantly increased T lymphocyte proliferation index. Piglets also had significantly increased levels of specific IgG1, IgG2a, CD4+, and CD8+ cells. The rMseno findings demonstrated a robust immunological response in mice and piglets, affording partial clinical protective efficacy in piglets.

SUBMITTER: Xue S 

PROVIDER: S-EPMC8708218 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>Mycoplasma suis</i> Alpha-Enolase Subunit Vaccine Induces an Immune Response in Experimental Animals.

Xue Shujiang S   Seo Kangseok K   Yang Miaosen M   Cui Chengdu C   Yang Meng M   Xiang Siyu S   Yan Zongbin Z   Wu Shengjun S   Han Jincheng J   Yu Xiaoyang X   Li Yunxiao Y   Jin Xin X  

Vaccines 20211220 12


Recombinant protein technology has emerged as an excellent option for vaccine development. However, prior to our study, the immune induction ability of recombinant <i>Mycoplasma suis</i> alpha-enolase (rMseno) in animals remained unclear. The purpose of this study was to develop a rMseno protein subunit vaccine and to determine its ability to elicit an immunological response. To accomplish this, we cloned the gene into pET-15b, expressed it in BL21 cells, and purified it. Following the establish  ...[more]

Similar Datasets

| S-EPMC2168360 | biostudies-literature
| S-EPMC8670867 | biostudies-literature
| S-EPMC11438903 | biostudies-literature
| S-EPMC3542004 | biostudies-literature
| S-EPMC4189797 | biostudies-literature
| PRJNA43297 | ENA
| S-EPMC11564553 | biostudies-literature
| S-EPMC2643536 | biostudies-literature
| S-EPMC11208943 | biostudies-literature
| S-EPMC6315727 | biostudies-literature